AU2984695A - 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists - Google Patents

4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists

Info

Publication number
AU2984695A
AU2984695A AU29846/95A AU2984695A AU2984695A AU 2984695 A AU2984695 A AU 2984695A AU 29846/95 A AU29846/95 A AU 29846/95A AU 2984695 A AU2984695 A AU 2984695A AU 2984695 A AU2984695 A AU 2984695A
Authority
AU
Australia
Prior art keywords
indeno
pyridine
hydroxy
phenyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29846/95A
Other languages
English (en)
Inventor
Jean-Claude Aloup
Francois Audiau
Michel Barreau
Dominique Damour
Arielle Genevois-Borella
Patrick Jimonet
Serge Mignani
Yves Ribeill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU2984695A publication Critical patent/AU2984695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU29846/95A 1994-07-20 1995-07-17 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists Abandoned AU2984695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9408999 1994-07-20
FR9408999A FR2722786B1 (fr) 1994-07-20 1994-07-20 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
PCT/FR1995/000952 WO1996002536A1 (fr) 1994-07-20 1995-07-17 Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one comme nmda antagonistes

Publications (1)

Publication Number Publication Date
AU2984695A true AU2984695A (en) 1996-02-16

Family

ID=9465588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29846/95A Abandoned AU2984695A (en) 1994-07-20 1995-07-17 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists

Country Status (6)

Country Link
EP (1) EP0772612A1 (fr)
JP (1) JPH10504027A (fr)
AU (1) AU2984695A (fr)
FR (1) FR2722786B1 (fr)
WO (1) WO1996002536A1 (fr)
ZA (1) ZA955942B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK11542003A3 (sk) * 2001-03-14 2004-07-07 Grnenthal Gmbh Substituované pyrazolopyrimidíny a tiazolopyrimidíny, spôsob ich výroby, liečivá tieto látky obsahujúce a ich použitie
WO2015088564A1 (fr) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. Composés modulateurs du récepteur p2x4
WO2015088565A1 (fr) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. Composés modulateurs du récepteur p2x4 et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233641A (en) * 1989-05-16 1992-07-28 Merrell Dow Pharma Quinoline and thienopyridine derivatives and excitatory amino acid antagonistic pharmaceutical compositions
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
EP0772612A1 (fr) 1997-05-14
ZA955942B (en) 1996-02-21
FR2722786A1 (fr) 1996-01-26
JPH10504027A (ja) 1998-04-14
WO1996002536A1 (fr) 1996-02-01
FR2722786B1 (fr) 1996-08-23

Similar Documents

Publication Publication Date Title
AU5276696A (en) Imidazo{1,2-a}pyridine derivatives
AU696241B2 (en) Dihydropyridine NPY antagonists: piperazine derivatives
AU6991996A (en) 2(1H)-quinolone derivatives as serotonin antagonists
AU7131196A (en) Pyrimidine derivatives as 5ht2c-receptor antagonists
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
IL125358A0 (en) 5H-thiazolo [3,2-a] pyrimidine derivatives
AU7214896A (en) Tetrahydroquinolines as nmda antagonists
ZA982969B (en) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives.
AU698867B2 (en) Fused imidazo 1,2-a pyridines
AU1882295A (en) Pyrrolo(2,3-(d))pyrimidine derivatives as antivirals
AU7986791A (en) Antipsychotic hexahydro-2h-indeno(1,2-c)pyridine derivatives
NZ326039A (en) Process for making 3,4-dihydro-pyrimidin-2(1h)-one derivatives
AU2984695A (en) 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists
AU2931099A (en) Crf antagonistic pyrazolo(4,3-b)pyridines
GB2316072B (en) Pyrrolo[3,2-c]quinoline derivatives
IL133512A0 (en) 5-substituted -3- oxadiazolyl - 1, 6-naphthyridin - 2 (1h) - one derivatives
AU1663399A (en) Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
AU4264096A (en) 3,4-dihydro-2,5,7,8-tetramethyl-benzopyran-6-ol derivatives for use as drugs
AU679184B2 (en) New pyridine derivatives as leukcotriene B4 antagonists
GR3033237T3 (en) Quinoline derivatives as leukoriene antagonists.
ZA957309B (en) New thiazolo[3,2-a]quinoline and -naphthyridine derivatives
ZA932721B (en) Substituted Indolizino[1,2-b]quinolinones
AU1224899A (en) Process for the preparation of acetal derivatives of 1,4-dihydropyridines
PL317859A1 (en) Novel derivative of isothiasole [5,4-b] pyridine
AU1655695A (en) 8-amino-pyrido (1,2,3-d,e)(1,3,4) benzoxadiazine derivatives